(S)-1-Boc-2-Isopropylpiperazine

Catalog No.: 
ACFPOE256
CAS No.: 
674792-05-3
Molecular Formula: 
C12H24N2O2
Molecular Weight: 
228.34
(S)-1-Boc-2-Isopropylpiperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$156.00In stockInquiry
25g98%$779.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-1-Boc-2-Isopropylpiperazine
IUPAC Nametert-butyl (S)-2-isopropylpiperazine-1-carboxylate
MDL No.MFCD03787918
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESCC([C@@H]1N(C(OC(C)(C)C)=O)CCNC1)C
InChI KeyNZTWGWFHWJARJX-SNVBAGLBSA-N
Synonym674792-05-3 | (S)-1-Boc-2-isopropylpiperazine | (S)-1-BOC-2-ISOPROPYL-PIPERAZINE | (S)-tert-butyl 2-isopropylpiperazine-1-carboxylate | tert-Butyl (2S)-2-(propan-2-yl)piperazine-1-carboxylate | tert-butyl (2S)-2-propan-2-ylpiperazine-1-carboxylate | MFCD03787918 | (S)-
CAS No.674792-05-3
PubChem CID17750439

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFPOE256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGQTY543 route compound structure diagram
    ACGQTY543674791-99-2In Stock
  2. Then
  3. ACFPOE256 route product structure diagram
    ACFPOE256674792-05-3In Stock
Inquiry

2. ACFPOE256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFPOE256 route product structure diagram
    ACFPOE256674792-05-3In Stock
Inquiry

3. ACFPOE256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFPOE256 route product structure diagram
    ACFPOE256674792-05-3In Stock
Inquiry

Comments (0)